Literature DB >> 23254892

Dietary patterns and colorectal adenomas in Lynch syndrome: the GEOLynch cohort study.

Akke Botma1, Hans F A Vasen, Fränzel J B van Duijnhoven, Jan H Kleibeuker, Fokko M Nagengast, Ellen Kampman.   

Abstract

BACKGROUND: Patients with Lynch syndrome (LS) have a high risk of developing colorectal cancer due to mutations in mismatch repair genes. Because dietary factors, alone and in combination, influence sporadic colorectal carcinogenesis, the association of dietary patterns with colorectal adenomas in LS patients was assessed.
METHODS: In the GEOLynch cohort of 486 persons with LS, dietary information was collected, using a food frequency questionnaire. Dietary pattern scores were obtained by principal components analysis. Hazard ratios (HR) between dietary patterns and colorectal adenomas were calculated using Cox regression models. Robust sandwich variance estimates were used to control for dependency within families. Final models were adjusted for age, sex, smoking habits, colorectal adenoma history, and extent of colon resection.
RESULTS: During a median follow-up of 20 months, colorectal adenomas were detected in 58 persons. Four dietary patterns were identified: a "Prudent," "Meat," "Snack," and "Cosmopolitan" pattern. Individuals within the highest tertile of the "Prudent" pattern had a HR of 0.73 (95% confidence interval [CI], 0.32-1.66) for colorectal adenomas, compared with the lowest tertile. Those with high "Meat" pattern scores had a HR of 1.70 (95% CI, 0.83-3.52). A high "Snack" pattern was associated with an increased risk of colorectal adenomas (HR, 2.16; 95% CI, 1.03-4.49). A HR of 1.25 (95% CI, 0.61-2.55) was observed for persons in the highest tertile of the "Cosmopolitan" pattern.
CONCLUSIONS: These findings suggest that dietary patterns may be associated with development of colorectal adenoma in patients with Lynch syndrome. The directions of these findings are corroborative with those observed in studies investigating sporadic colorectal cancer.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Year:  2012        PMID: 23254892     DOI: 10.1002/cncr.27726

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic review.

Authors:  Adriana M Coletta; Susan K Peterson; Leticia A Gatus; Kate J Krause; Susan M Schembre; Susan C Gilchrist; Mala Pande; Eduardo Vilar; Y Nancy You; Miguel A Rodriguez-Bigas; Larkin L Strong; Patrick M Lynch; Karen H Lu; Karen Basen-Engquist
Journal:  Fam Cancer       Date:  2019-06-24       Impact factor: 2.375

Review 2.  Do lifestyle factors influence colorectal cancer risk in Lynch syndrome?

Authors:  Fränzel J B van Duijnhoven; Akke Botma; Renate Winkels; Fokko M Nagengast; Hans F A Vasen; Ellen Kampman
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

Review 3.  Colorectal Cancer in Young Adults.

Authors:  Anand Venugopal; Elena M Stoffel
Journal:  Curr Treat Options Gastroenterol       Date:  2019-03

4.  Inaccurate data in meta-analysis 'Dietary patterns and colorectal cancer risk: a meta-analysis'.

Authors:  Fred K Tabung
Journal:  Eur J Cancer Prev       Date:  2019-01       Impact factor: 2.497

5.  Dietary Supplement Use and Colorectal Adenoma Risk in Individuals with Lynch Syndrome: The GEOLynch Cohort Study.

Authors:  Renate C Heine-Bröring; Renate M Winkels; Akke Botma; Fränzel J B van Duijnhoven; Audrey Y Jung; Jan H Kleibeuker; Fokko M Nagengast; Hans F A Vasen; Ellen Kampman
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

Review 6.  Update on Lynch syndrome genomics.

Authors:  Päivi Peltomäki
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

7.  Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts.

Authors:  Hans F A Vasen; Ignacio Blanco; Katja Aktan-Collan; Jessica P Gopie; Angel Alonso; Stefan Aretz; Inge Bernstein; Lucio Bertario; John Burn; Gabriel Capella; Chrystelle Colas; Christoph Engel; Ian M Frayling; Maurizio Genuardi; Karl Heinimann; Frederik J Hes; Shirley V Hodgson; John A Karagiannis; Fiona Lalloo; Annika Lindblom; Jukka-Pekka Mecklin; Pal Møller; Torben Myrhoj; Fokko M Nagengast; Yann Parc; Maurizio Ponz de Leon; Laura Renkonen-Sinisalo; Julian R Sampson; Astrid Stormorken; Rolf H Sijmons; Sabine Tejpar; Huw J W Thomas; Nils Rahner; Juul T Wijnen; Heikki Juhani Järvinen; Gabriela Möslein
Journal:  Gut       Date:  2013-02-13       Impact factor: 23.059

8.  Physical activity and the risk of colorectal cancer in Lynch syndrome.

Authors:  S Ghazaleh Dashti; Aung Ko Win; Sheetal S Hardikar; Stephen E Glombicki; Sheila Mallenahalli; Selvi Thirumurthi; Susan K Peterson; Y Nancy You; Daniel D Buchanan; Jane C Figueiredo; Peter T Campbell; Steven Gallinger; Polly A Newcomb; John D Potter; Noralane M Lindor; Loic Le Marchand; Robert W Haile; John L Hopper; Mark A Jenkins; Karen M Basen-Engquist; Patrick M Lynch; Mala Pande
Journal:  Int J Cancer       Date:  2018-08-07       Impact factor: 7.316

9.  Risk Factors Associated with Colorectal Cancer in a Subset of Patients with Mutations in MLH1 and MSH2 in Taiwan Fulfilling the Amsterdam II Criteria for Lynch Syndrome.

Authors:  Abram Bunya Kamiza; Ling-Ling Hsieh; Reiping Tang; Huei-Tzu Chien; Chih-Hsiung Lai; Li-Ling Chiu; Tsai-Ping Lo; Kuan-Yi Hung; Chun-Yi Wang; Jeng-Fu You; Chao A Hsiung; Chih-Ching Yeh
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

10.  Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry.

Authors:  Hans F A Vasen; Mary E Velthuizen; Jan H Kleibeuker; Fred H Menko; Fokke M Nagengast; Annemieke Cats; Andrea E van der Meulen-de Jong; Martijn H Breuning; Anne J Roukema; Inge van Leeuwen-Cornelisse; Wouter H de Vos Tot Nederveen Cappel; Juul T Wijnen
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.